Clinical profile of patients with 46 XY disorders of sex development: a single centered experience
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20211521Keywords:
Clinical profile, Hormone replacement therapy, Reconstructive surgeries, XY disorders of sex developmentAbstract
Background: XY disorders of sex development are a complex entity that needs medical attention from childhood to adolescence and throughout life. The aim of the study was to analyze retrospectively the medical records of subjects with 46 XY disorders of sex development (DSD) and characterize their clinical profile and management course in a tertiary care centre.
Methods: 32 subjects with 46 XY DSD attending Endocrinology OPD / Gynecology between 2010 to 2020 were enrolled in the study. Data collected includes age at presentation, symptoms, sex of rearing, phenotype, external masculinisation score (EMS), karyotyping, gonadal features like location and histopathology, psychosexual domain and their management and follow up. Statistical Analysis: The mean and standard deviation was calculated for normally distributed data.
Results: The mean (SD) age of all study subjects (n=32) were 15.5 ± 5.32 years. 46 XY DSD included cases of complete gonadal dysgenesis (n=6), mixed gonadal dysgenesis (n=6), complete androgen biosynthetic defects (n=9), partial gonadal dysgenesis (n=2), 5-alpha-reductase type 2 deficiency (n=8) and 17 betahydroxysteroid deficiency (n=1). The most common clinical presentation was for primary amenorrhea followed by genital ambiguity and virilisation in females. Resection of testis at the earliest or a biopsy of the testis if resection is postponed in a female sex assigned 46 XY DSD is favored. Male sex assigned 46 XY DSD needs corrective surgeries and orchidopexy for undescented viable testis with periodic follow up for testicular malignancy.
Conclusions: 46 XY DSD’s may shares similarities in their clinical presentation, though age of presentation may be in a wide range. Proper gender assignment, gonadectomy, reconstructive surgeries, hormone replacement and time to time follow up for testicular malignancy in cases where the testes are preserved is the ideal management.
References
Lee PA, Houk CP. Ahmed SF. Consensus statement on management of intersex disorders. International consensus conference on intersex. Pediatrics. 2006;118:e488-e500.
Goyal A, Kubihal S, Gupta Y. Dynamic testing for evaluation of adrenal and gonadal function in pediatric and adult endocrinology: An overview. Indian J EndocrMetab. 2019;23:593-601.
Ahmed SF, Khwaja O, Hughes IA. The role of a clinical score in the assessment of ambiguous genitalia. BJU Int. 2000;85:120-12.
Lovell‑Badge R. The role of Sry in mammalian sex determination. Ciba Found Symp. 1992;165:162‑79.
Rey R, Lukas‑Croisier C, Lasala C, Bedecarrás P. AMH/MIS: What we know already about the gene, the protein and its regulation. Mol Cell Endocrinol 2003;211:21‑31.
Cools M, Boter M, van Gurp R, Stoop H, Poddighem P. Impact of the Y-containing cell line on histological differentiation patterns in dysgenetic gonads. Clinical Endocrinol. 2007;67:184-192.
Farrugia MK, Sebire NJ, Achermann JC, Eisawi A, Duffy PG, Mushtaq I. Clinical and gonadal features and early surgical management of 45,X/46,XY and 45,X/47,XYY chromosomal mosaicism presenting with genital anomalies. J Pediatr Urol. 2013;9(2):139‐144.
McCann‑Crosby B, Mansouri R, Dietrich JE, McCullough LB, Sutton VR, Austin EG, et al. State of the art review in gonadal dysgenesis: Challenges in diagnosis and management. Int J Pediatr Endocrinol. 2014;2014:4.
Cools M, Pleskacova J, Stoop H. On behalf of the Mosaicism Collaborative Group, Gonadal Pathology and Tumor Risk in Relation to Clinical Characteristics in Patients with 45,X/46,XY Mosaicism, The Journal of Clinical Endocrinology & Metabolism. 2011;96:1171-80.
Liu AX, Shi HY, Cai ZJ. Increased risk of gonadal malignancy and prophylactic gonadectomy: a study of 102 phenotypic female patients with Y chromosome or Y-derived sequences. Human Reproduction. 2014;29:1413-9.
Das DV, Jabbar PK, Gomez R, Seena TP. Hemoptysis: A rare presentation of mixed gonadal dysgenesis. J Hum Reprod Sci. 2020;13:242-4.
Das S, Saikia UK, Saikia KK, Sarma D, Choudhury BK, Bhuyan AK, et al. “Spectrum of 46 XY disorders of sex development”: A hospital based cross sectional study. Indian J Endocr Metab. 2020;24:360-5.
Cools M, Wolffenbuttel KP, Hersmus R. Malignant testicular germ cell tumors in postpubertal individuals with androgen insensitivity: prevalence, pathology and relevance of single nucleotide polymorphism-based susceptibility profiling, Human Reproduction. 2017;32:2561-73.
